0001225208-19-002351.txt : 20190212 0001225208-19-002351.hdr.sgml : 20190212 20190212211459 ACCESSION NUMBER: 0001225208-19-002351 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20190208 FILED AS OF DATE: 20190212 DATE AS OF CHANGE: 20190212 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sneed Michael E CENTRAL INDEX KEY: 0001745939 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-03215 FILM NUMBER: 19593008 MAIL ADDRESS: STREET 1: JOHNSON & JOHNSON STREET 2: ONE JOHNSON & JOHNSON PLAZA CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: JOHNSON & JOHNSON CENTRAL INDEX KEY: 0000200406 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 221024240 STATE OF INCORPORATION: NJ FISCAL YEAR END: 0101 BUSINESS ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 BUSINESS PHONE: 732-524-2455 MAIL ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 4 1 doc4.xml X0306 4 2019-02-08 0000200406 JOHNSON & JOHNSON JNJ 0001745939 Sneed Michael E ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933 1 EVP, Global Corp Aff & COO Common Stock 2019-02-08 4 M 0 6365.0000 0 A 46239.0000 D Common Stock 2019-02-08 4 F 0 1827.0000 132.0000 D 44412.0000 D Common Stock 2019-02-11 4 M 0 7275.0000 0.0000 A 51687.0000 D Common Stock 2019-02-11 4 A 0 1193.0000 0.0000 A 52880.0000 D Common Stock 2019-02-11 4 F 0 3497.0000 131.9400 D 49383.0000 D Common Stock 2331.0000 I By 401k Common Stock 1268.0000 I By ESOP Restricted Share Units 2019-02-08 4 M 0 6365.0000 0.0000 D 2019-02-08 Common Stock 6365.0000 0.0000 D Employee Stock Options (Right to Buy) 131.9400 2019-02-11 4 A 0 31003.0000 0.0000 A 2022-02-11 2029-02-11 Common Stock 31003.0000 31003.0000 D Performance Share Units 0.0000 2019-02-11 4 M 0 7275.0000 0.0000 D 2019-02-08 Common Stock 7275.0000 0.0000 D Restricted Share Units 0.0000 2019-02-11 4 A 0 1517.0000 0.0000 A 2022-02-11 Common Stock 1517.0000 1517.0000 D Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting. Shares withheld for payment of taxes upon vesting of Restricted Share Units. Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. Shares earned due to performance factor of 116.4% upon vesting of Performance Share Units and certification of performance results by the Board. Shares withheld for payment of taxes upon vesting of Performance Share Units and certification of performance results by the Board. Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2019). Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2019). Awarded under Issuer's Long-Term Incentive Plan. Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. poasneed.txt Linda E King, as attorney-in-fact for Michael E. Sneed 2019-02-12 EX-24 2 poasneed.txt POWER OF ATTORNEY Executive Officers Know all persons by these presents, that the undersigned hereby constitutes and appoints each of Thomas J. Spellman III, Renee A. Brutus, Michelle R. Ryan, Linda E. King and Maria A. Frucci, signing singly, as the undersigned's true and lawful attorneys-in-fact to: (1) complete and execute for and on behalf of the undersigned, in the undersigned's capacity as an executive officer of Johnson & Johnson (the "Company"), Forms 3, 4 and 5 (including any amendments thereto) in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder (the "Exchange Act") and Form 144 in accordance with Rule 144 of the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder (the "Securities Act"); (2) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4, 5 and 144 (including any amendments thereto) and timely file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and (3) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion. The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, (i) any of the undersigned's responsibilities to comply with Section 16 of the Exchange Act or Rule 144 of the Securities Act or (ii) any liability of the undersigned for failure to comply with such requirements. The undersigned agrees that each such attorney-in-fact may rely entirely on information furnished orally or in writing by or at the direction of the undersigned to the attorney-in-fact. This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, 5 and 144 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of the date set forth below. /s/ Michael E. Sneed Name: Michael E. Sneed Date: November 5, 2018